RE: CLN's20 Jan 2021 11:39
No deal, sub 6, Note the words The Company, not we:
pharmaceutical company ("GlobalCo"). As a result of the Company's successful collaboration with GlobalCo, the Company has chosen a clone of its CDX antibody that is ready for investigational new drug ("IND") application-enabling studies, a significant step toward clinical trials.